Now that vaccinated people need the monoclonal treatments, Biden admin and media attack the treatment
written by David Horowitz 9/20/2021
For those of you who couldn’t believe that the government’s war on ivermectin and every other treatment was rooted in a sinister motivation, its new attack on the monoclonal antibodies should indelibly cement the terrifying thought in your mind. The government and the media are now using the same attack pattern on the monoclonal antibody treatment that they used on hydroxychloroquine and ivermectin now that it has become popular with people desperate for treatment – vaccinated and unvaccinated alike.
On Sept. 14, the Biden administration announced that the feds would be cutting the number of monoclonal treatments per week in the southern states and reallocating them as part of a broader plan to start rationing the treatments. For example, in Florida, HHS issued an allocation for the week of Sept. 13 of 3,100 doses of BAM/ETE treatments and 27,850 doses of REGN-COV. As Florida Gov. Ron DeSantis said in a press conference last week, this would effectively reduce Florida’s allocation by 50%. The federal agency did this without any warning or indication that there was a shortage.
Then, last Thursday, White House press secretary Jen Psaki explained the move as follows: “Our supply is not unlimited and we believe it should be equitable.” HHS then followed up with an explanation of the policy of “equity.”
But wouldn’t you focus on where it’s needed at a given time rather than blind “equity”? Also, Biden promised just days earlier during the announcement of his vaccine mandate to boost monoclonal distribution by 50%.
Well, here is the answer to the enigma: In that same announcement, Biden warned, “If these governors won’t help us beat the pandemic, I’ll use my power as president to get them out of the way.” Is the federal takeover of the monoclonals his ace in the hole? And why wouldn’t the government just produce more? We have spent trillions of dollars on welfare, shutdowns, and vaccines that failed so miserably that people who already got the shots still need the monoclonals! So why not put the funding into the monoclonals?
Fair use excerpt. Read the whole article here.